Could A Mega Merger Between Unilever plc And Reckitt Benckiser Group Plc Be In The Works?

A mega merger between Unilever plc (LON:ULVR) and Reckitt Benckiser Group Plc (LON:RB) could be on the cards.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

A few years ago, brokers across the City were starting to talk about the possibility of a mega merger between two FTSE 100 giants, Unilever (LSE: ULVR) (NYSE: UL.US) and Reckitt Benckiser (LSE: RB) (NASDAQOTH: RBGPF.US). 

However, although the time was right for a deal, no offer ever came. But now the two companies are perfectly positioned for a merger, as the M&A boom continues to heat up.  

UnileverPerfect fit

Even at first glance, Unilever and Reckitt appear to be an excellent fit. Both companies own and manufacture some of the world’s most recognisable cleaning products. For example, Reckitt produces brands such as Dettol, Finish, Cillit bang and Vanish, while Unilever’s portfolio includes DomestosCif and Dove

What’s more, both Unilever and Reckitt manufacture many consumer products, such as Durex and Lynx. With so many brands, many of which are household names, bought together under one roof, the merger could generate impressive cost savings, as Reckitt and Unilever merged production facilities and distribution networks. 

reckitt.benckiserMerger catalysts

There are a number of recent catalysts that make me think a deal could be round the corner.

Firstly, Reckitt has finally concluded a strategic review of its pharmaceutical business, which it started back in October. The company’s pharmaceutical unit, which produces the heroin substitute Suboxone has been denting Reckitt’s performance recently. 

Indeed, Reckitt’s first quarter results revealed that the pharmaceutical division’s sales fell 11% during period, while the non-pharmaceutical divisions reported sales growth of 4%. Reckitt’s desire to sell, or offload this division, could re-ignite Unilever’s interest in the remaining group. 

Meanwhile, Unilever itself is also busy reshaping its operations. In particular, the group is divesting non-core, low-margin food products and other consumer goods, in order to focus on cleaning products.  Returns from food products have deteriorated during the past few years, due to rising costs and increasing competition. The sale of this non-core brands should bring Unilever’s product offering more into line with that of Reckitt. 

Unilever’s recent non-core divestments include its meat snacks business, the Peperami brand, the Ragu and Bertolli pasta sauces brands and, during the past few days, the company has sold its US Slim Fast brand.

The bottom line

So all in all, Unilever and Reckitt would make a perfect fit and recent developments at both companies make me believe that a merger may be imminent. 

Both Unilever and Reckitt have started a process of selling off non-core brands, which when completed, will leave the two companies with a concentrated portfolio of cleaning products.

A merger between the two would allow the combined group to cut manufacturing costs and reduce the prices of its products. The combined Unilever-Reckitt would be in a strong position to grab market share and drive sales, both within the UK and across developing markets.

Rupert Hargreaves has no position in any shares mentioned.  The Motley Fool owns shares of Unilever.

More on Investing Articles

British pound data
Investing Articles

Starting with nothing? Here’s why now is the perfect time to start building a passive income

Many are worried that 2026 might be a bad time to start investing in stocks and shares. Our Foolish author…

Read more »

ISA coins
Investing Articles

Decided not to bother with a Stocks and Shares ISA? You might be missing these 3 things!

With a fresh annual allowance for contributing to a Stocks and Shares ISA upon us, what might people who don't…

Read more »

GSK scientist holding lab syringe
Investing Articles

Why is everyone buying GSK shares?

GSK shares have been outperforming the FTSE 100 in 2026. Paul Summers takes a closer look and asks whether this…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

£10,000 invested in easyJet shares at the start of 2026 is now worth…

Anyone buying easyJet shares will have endured a rough ride since January. Paul Summers wonders whether things could get even…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

5 years ago, £5,000 bought 2,645 Barclays shares. But how many would it buy now?

Despite delivering an impressive return since April 2021, Barclays' shares have lagged the FTSE 100's other banks. James Beard considers…

Read more »

Side of boat fuelled by gas to liquids, advertising Shell GTL Fuel
Investing Articles

5 years ago, £5,000 bought 354 Shell shares. But how many would it buy now?

When it comes to Shell’s numbers, most of them are impressive. And it’s no different when looking at the recent…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

I asked ChatGPT if I should buy Aviva, Diageo or BAE Systems stock and it said…

Aviva, Diageo and BAE Systems shares are popular FTSE 100 picks. But which of the three does ChatGPT like the…

Read more »

Tesla car at super charger station
Investing Articles

SpaceX’s IPO threatens to leave the Tesla share price on the forecourt

As Elon Musk starts fuelling the engines for a SpaceX IPO, could the Tesla share price get left in the…

Read more »